2027 Agenda

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Dr. Heather Goff is a Professor of Dermatololgy at UT Southwestern Medical Center in Dallas, Texas where she directs a clinic in the treatment of cutaneous lymphomas. She is a course director for dermatology at UT Southwestern medical school and was a founding member of the Basic Dermatology Curriculum Workgroup at the American Academy of Dermatology. She utilizes her background in fine art to collaborate with local art museums in a medical school elective entitled the Art of Observation.

Scott Elman, MD, FAAD is an Assistant Professor of Dermatology in the Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine who also serves as the Director of Inpatient Dermatology Services at the University of Miami Hospital. Dr. Elman received his Medical Degree from Harvard Medical School in 2016, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. He is an active member of the Medical Dermatology Society, the Rheumatologic Dermatology Society and the Society of Dermatology Hospitalists. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and two children.

Dr. Jennifer Cao completed her medical degree at Baylor College of Medicine, followed by an Internal Medicine internship at Carolinas Medical Center, and ophthalmology residency at the University of Colorado. She then completed a fellowship in Uveitis and Ocular Immunology at the Massachusetts Eye and Surgery Institution (MERSI) with Dr. Stephen Foster, who is widely regarded as the “father” of modern uveitis care.
Dr. Cao is a board certified ophthalmologist and is an Associate Professor in the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas, Texas. She is one of the rare uveitis specialists whose practice is 100% comprised of uveitis and ocular inflammatory disease patients, and who also manages the full spectrum of immunomodulatory therapies for her patients.

Dr. Jennifer Cao completed her medical degree at Baylor College of Medicine, followed by an Internal Medicine internship at Carolinas Medical Center, and ophthalmology residency at the University of Colorado. She then completed a fellowship in Uveitis and Ocular Immunology at the Massachusetts Eye and Surgery Institution (MERSI) with Dr. Stephen Foster, who is widely regarded as the “father” of modern uveitis care.
Dr. Cao is a board certified ophthalmologist and is an Associate Professor in the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas, Texas. She is one of the rare uveitis specialists whose practice is 100% comprised of uveitis and ocular inflammatory disease patients, and who also manages the full spectrum of immunomodulatory therapies for her patients.

Scott Elman, MD, FAAD is an Assistant Professor of Dermatology in the Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine who also serves as the Director of Inpatient Dermatology Services at the University of Miami Hospital. Dr. Elman received his Medical Degree from Harvard Medical School in 2016, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. He is an active member of the Medical Dermatology Society, the Rheumatologic Dermatology Society and the Society of Dermatology Hospitalists. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and two children.

Dr. Heather Goff is a Professor of Dermatololgy at UT Southwestern Medical Center in Dallas, Texas where she directs a clinic in the treatment of cutaneous lymphomas. She is a course director for dermatology at UT Southwestern medical school and was a founding member of the Basic Dermatology Curriculum Workgroup at the American Academy of Dermatology. She utilizes her background in fine art to collaborate with local art museums in a medical school elective entitled the Art of Observation.

Dr. Weber is the Director of the Cardio-Dermatology and Cardio-Rheumatology Program, and an Assistant Professor of Medicine at UT Southwestern Medical Center. She is a graduate of the University of Pennsylvania School of Medicine with an MD-PhD in Immunology. She received internal medicine training, including serving as a chief medical resident, and cardiovascular training, including an advanced cardiovascular imaging research fellowship at the Brigham and Women’s Hospital. Her clinical interests include cardiovascular risk stratification and prevention with patients with systemic inflammatory disorders. Her research leverages advanced cardiovascular imaging (stress/PET and coronary CT), biomarkers, and immunology to investigate the relationships between systemic inflammation and CVD, with a focus on the coronary microcirculation and novel metrics of atherosclerotic plaque imaging. Her multi-disciplinary clinical and research program includes close collaborations between cardiology, rheumatology, and dermatology. As a testament to her success in this short time frame, she is the recipient of the 2025 American College of Cardiology (ACC) Douglas P. Zipes Distinguished Young Scientist Award.

Katherine Economy
MD
Division Chief Mass General Brigham
Co-Director Program for Cardiac Disease in Pregnancy
Brigham and Women’s Hospital
Program Director Maternal Fetal Medicine Fellowship
Brigham and Women’s Hospital
Mass General Brigham

Katherine Economy, MD is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She is the Division Chief for Maternal Fetal Medicine at Mass General Brigham and Co-Directs the Program for Heart Disease in Pregnancy at Brigham and Women’s Hospital. As a maternal-fetal medicine subspecialist, Kathy is especially drawn to clinical challenges at the interface of obstetrics and internal medicine, with a focus on cardiovascular disease in pregnancy. Through the development of multidisciplinary clinical programs, educating fellows, and serving in national service roles, she has worked to enhance both individual patient care and broader clinical standards in her field. Kathy is especially passionate about mentoring and teaching the next generation of clinicians. Outside of work, Kathy enjoys traveling and spending time with her family.

Dr. Heather Goff is a Professor of Dermatololgy at UT Southwestern Medical Center in Dallas, Texas where she directs a clinic in the treatment of cutaneous lymphomas. She is a course director for dermatology at UT Southwestern medical school and was a founding member of the Basic Dermatology Curriculum Workgroup at the American Academy of Dermatology. She utilizes her background in fine art to collaborate with local art museums in a medical school elective entitled the Art of Observation.

Dr. Swanson is a board-certified dermatologist and pediatric dermatologist. She obtained her medical degree from Tulane University School of Medicine in New Orleans. She performed her dermatology residency at Mayo Clinic in Rochester, Minnesota. After that, she completed a fellowship in Pediatric Dermatology at Phoenix Children’s Hospital in Arizona. She was in private practice in Colorado from 2011 thru 2020. She moved to Boise, Idaho in summer 2020 to become the first and only pediatric dermatologist in the state of Idaho.

She is active in local and national medical societies and organizations. She loves lecturing at conferences discussing pediatric dermatology with audiences across the country. Since moving to Idaho, she works in private practice at Ada West Dermatology and she is on staff at St Luke’s Children’s Hospital where she sees hospital consults and performs procedures.

Katherine Economy
MD
Division Chief Mass General Brigham
Co-Director Program for Cardiac Disease in Pregnancy
Brigham and Women’s Hospital
Program Director Maternal Fetal Medicine Fellowship
Brigham and Women’s Hospital
Mass General Brigham

Katherine Economy, MD is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She is the Division Chief for Maternal Fetal Medicine at Mass General Brigham and Co-Directs the Program for Heart Disease in Pregnancy at Brigham and Women’s Hospital. As a maternal-fetal medicine subspecialist, Kathy is especially drawn to clinical challenges at the interface of obstetrics and internal medicine, with a focus on cardiovascular disease in pregnancy. Through the development of multidisciplinary clinical programs, educating fellows, and serving in national service roles, she has worked to enhance both individual patient care and broader clinical standards in her field. Kathy is especially passionate about mentoring and teaching the next generation of clinicians. Outside of work, Kathy enjoys traveling and spending time with her family.

Dr. Heather Goff is a Professor of Dermatololgy at UT Southwestern Medical Center in Dallas, Texas where she directs a clinic in the treatment of cutaneous lymphomas. She is a course director for dermatology at UT Southwestern medical school and was a founding member of the Basic Dermatology Curriculum Workgroup at the American Academy of Dermatology. She utilizes her background in fine art to collaborate with local art museums in a medical school elective entitled the Art of Observation.

Dr. Swanson is a board-certified dermatologist and pediatric dermatologist. She obtained her medical degree from Tulane University School of Medicine in New Orleans. She performed her dermatology residency at Mayo Clinic in Rochester, Minnesota. After that, she completed a fellowship in Pediatric Dermatology at Phoenix Children’s Hospital in Arizona. She was in private practice in Colorado from 2011 thru 2020. She moved to Boise, Idaho in summer 2020 to become the first and only pediatric dermatologist in the state of Idaho.

She is active in local and national medical societies and organizations. She loves lecturing at conferences discussing pediatric dermatology with audiences across the country. Since moving to Idaho, she works in private practice at Ada West Dermatology and she is on staff at St Luke’s Children’s Hospital where she sees hospital consults and performs procedures.

Dr. Weber is the Director of the Cardio-Dermatology and Cardio-Rheumatology Program, and an Assistant Professor of Medicine at UT Southwestern Medical Center. She is a graduate of the University of Pennsylvania School of Medicine with an MD-PhD in Immunology. She received internal medicine training, including serving as a chief medical resident, and cardiovascular training, including an advanced cardiovascular imaging research fellowship at the Brigham and Women’s Hospital. Her clinical interests include cardiovascular risk stratification and prevention with patients with systemic inflammatory disorders. Her research leverages advanced cardiovascular imaging (stress/PET and coronary CT), biomarkers, and immunology to investigate the relationships between systemic inflammation and CVD, with a focus on the coronary microcirculation and novel metrics of atherosclerotic plaque imaging. Her multi-disciplinary clinical and research program includes close collaborations between cardiology, rheumatology, and dermatology. As a testament to her success in this short time frame, she is the recipient of the 2025 American College of Cardiology (ACC) Douglas P. Zipes Distinguished Young Scientist Award.

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

David E. Fisher, MD, PhD, Chief of the Massachusetts General Hospital Department of Dermatology from 2008 to 2025, is the Edward Wigglesworth Professor of Dermatology Harvard Medical School. He also serves as director of Mass General’s Cutaneous Biology Research Center and director of its multidisciplinary Melanoma Center. A professor of dermatology and pediatrics at Harvard Medical School, Dr. Fisher came to MGH from the Dana-Farber Cancer Institute, where he previously directed the melanoma program. Dr. Fisher’s research has focused on understanding molecular and genetic events which underlie formation of melanoma and skin pigmentation. As a clinician, he has worked to translate these understandings into advances in diagnosis, treatment and prevention of human diseases related to skin and associated disorders. Dr. Fisher is a 2020 inductee into the National Academy of Medicine. In 2022 he was selected to Direct the Melanoma Academy run by the US Department of Defense. And in 2025 he was selected as Fellow of the American Academy of Cancer Research (FAACR).

He received his doctorate under Nobel Laureate Gunter Blobel and Henry Kunkel at Rockefeller University and his medical degree at Cornell Medical College. Dr. Fisher’s specialty training in Medicine, Pediatrics, Oncology were carried out at MGH, Dana-Farber, Boston Children’s, Brigham and Women’s. His research contributions include elucidation of the pathway through which UV radiation induces pigmentation, identification of MITF as master transcriptional regulator in melanocytes and melanoma oncogene, novel approaches to melanoma treatment and prevention, and discovery of the link between ultraviolet radiation and addictive behaviors.

Katherine Economy
MD
Division Chief Mass General Brigham
Co-Director Program for Cardiac Disease in Pregnancy
Brigham and Women’s Hospital
Program Director Maternal Fetal Medicine Fellowship
Brigham and Women’s Hospital
Mass General Brigham

Katherine Economy, MD is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She is the Division Chief for Maternal Fetal Medicine at Mass General Brigham and Co-Directs the Program for Heart Disease in Pregnancy at Brigham and Women’s Hospital. As a maternal-fetal medicine subspecialist, Kathy is especially drawn to clinical challenges at the interface of obstetrics and internal medicine, with a focus on cardiovascular disease in pregnancy. Through the development of multidisciplinary clinical programs, educating fellows, and serving in national service roles, she has worked to enhance both individual patient care and broader clinical standards in her field. Kathy is especially passionate about mentoring and teaching the next generation of clinicians. Outside of work, Kathy enjoys traveling and spending time with her family.

Katherine Economy
MD
Division Chief Mass General Brigham
Co-Director Program for Cardiac Disease in Pregnancy
Brigham and Women’s Hospital
Program Director Maternal Fetal Medicine Fellowship
Brigham and Women’s Hospital
Mass General Brigham

Katherine Economy, MD is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She is the Division Chief for Maternal Fetal Medicine at Mass General Brigham and Co-Directs the Program for Heart Disease in Pregnancy at Brigham and Women’s Hospital. As a maternal-fetal medicine subspecialist, Kathy is especially drawn to clinical challenges at the interface of obstetrics and internal medicine, with a focus on cardiovascular disease in pregnancy. Through the development of multidisciplinary clinical programs, educating fellows, and serving in national service roles, she has worked to enhance both individual patient care and broader clinical standards in her field. Kathy is especially passionate about mentoring and teaching the next generation of clinicians. Outside of work, Kathy enjoys traveling and spending time with her family.

David E. Fisher, MD, PhD, Chief of the Massachusetts General Hospital Department of Dermatology from 2008 to 2025, is the Edward Wigglesworth Professor of Dermatology Harvard Medical School. He also serves as director of Mass General’s Cutaneous Biology Research Center and director of its multidisciplinary Melanoma Center. A professor of dermatology and pediatrics at Harvard Medical School, Dr. Fisher came to MGH from the Dana-Farber Cancer Institute, where he previously directed the melanoma program. Dr. Fisher’s research has focused on understanding molecular and genetic events which underlie formation of melanoma and skin pigmentation. As a clinician, he has worked to translate these understandings into advances in diagnosis, treatment and prevention of human diseases related to skin and associated disorders. Dr. Fisher is a 2020 inductee into the National Academy of Medicine. In 2022 he was selected to Direct the Melanoma Academy run by the US Department of Defense. And in 2025 he was selected as Fellow of the American Academy of Cancer Research (FAACR).

He received his doctorate under Nobel Laureate Gunter Blobel and Henry Kunkel at Rockefeller University and his medical degree at Cornell Medical College. Dr. Fisher’s specialty training in Medicine, Pediatrics, Oncology were carried out at MGH, Dana-Farber, Boston Children’s, Brigham and Women’s. His research contributions include elucidation of the pathway through which UV radiation induces pigmentation, identification of MITF as master transcriptional regulator in melanocytes and melanoma oncogene, novel approaches to melanoma treatment and prevention, and discovery of the link between ultraviolet radiation and addictive behaviors.

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

Scott Elman, MD, FAAD is an Assistant Professor of Dermatology in the Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine who also serves as the Director of Inpatient Dermatology Services at the University of Miami Hospital. Dr. Elman received his Medical Degree from Harvard Medical School in 2016, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. He is an active member of the Medical Dermatology Society, the Rheumatologic Dermatology Society and the Society of Dermatology Hospitalists. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and two children.

Scott Elman, MD, FAAD is an Assistant Professor of Dermatology in the Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine who also serves as the Director of Inpatient Dermatology Services at the University of Miami Hospital. Dr. Elman received his Medical Degree from Harvard Medical School in 2016, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. He is an active member of the Medical Dermatology Society, the Rheumatologic Dermatology Society and the Society of Dermatology Hospitalists. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and two children.

Ryan Stidham is a translational scientist caring exclusively for patients with Crohn’s disease and ulcerative colitis. Ryan joined Mayo Clinic Florida in 2025 with a joint appointment in the Division of Gastroenterology and the Department of Artificial Intelligence and Informatics, where he serves as the Director of AI Clinical Partnerships. Prior to this he was a tenured Professor in both the Department of Computational Medicine & Bioinformatics and Department of Medicine where he served as the Associate Chair of Translational Research.

His research focus is technology development for improving disease activity measurement, clinical trial endpoint development, and automating care in IBD. Dr. Stidham’s research team has been supported by the National Institutes of Health, the Department of Defense, the National Science Foundation, the Crohn’s and Colitis Foundation, the Broad Foundation, the Leona Helmsley Charitable Trust, and several industry sponsored research collaborations. His team's work has been licensed by several technology companies and is being actively used in drug development.

Dr. Stidham received his medical degree from the University of Virginia School of Medicine, completed his internal medicine training at the University of Pennsylvania, and was an NIH T-32 Research Fellow of Gastroenterology at the University of Michigan. Dr. Stidham has advanced training in medical imaging physics, signals analysis, electronic data management, and clinical research design and statistical analysis.

Scott Elman, MD, FAAD is an Assistant Professor of Dermatology in the Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine who also serves as the Director of Inpatient Dermatology Services at the University of Miami Hospital. Dr. Elman received his Medical Degree from Harvard Medical School in 2016, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. He is an active member of the Medical Dermatology Society, the Rheumatologic Dermatology Society and the Society of Dermatology Hospitalists. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and two children.

Scott Elman, MD, FAAD is an Assistant Professor of Dermatology in the Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine who also serves as the Director of Inpatient Dermatology Services at the University of Miami Hospital. Dr. Elman received his Medical Degree from Harvard Medical School in 2016, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. He is an active member of the Medical Dermatology Society, the Rheumatologic Dermatology Society and the Society of Dermatology Hospitalists. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and two children.

Ryan Stidham is a translational scientist caring exclusively for patients with Crohn’s disease and ulcerative colitis. Ryan joined Mayo Clinic Florida in 2025 with a joint appointment in the Division of Gastroenterology and the Department of Artificial Intelligence and Informatics, where he serves as the Director of AI Clinical Partnerships. Prior to this he was a tenured Professor in both the Department of Computational Medicine & Bioinformatics and Department of Medicine where he served as the Associate Chair of Translational Research.

His research focus is technology development for improving disease activity measurement, clinical trial endpoint development, and automating care in IBD. Dr. Stidham’s research team has been supported by the National Institutes of Health, the Department of Defense, the National Science Foundation, the Crohn’s and Colitis Foundation, the Broad Foundation, the Leona Helmsley Charitable Trust, and several industry sponsored research collaborations. His team's work has been licensed by several technology companies and is being actively used in drug development.

Dr. Stidham received his medical degree from the University of Virginia School of Medicine, completed his internal medicine training at the University of Pennsylvania, and was an NIH T-32 Research Fellow of Gastroenterology at the University of Michigan. Dr. Stidham has advanced training in medical imaging physics, signals analysis, electronic data management, and clinical research design and statistical analysis.

David E. Fisher, MD, PhD, Chief of the Massachusetts General Hospital Department of Dermatology from 2008 to 2025, is the Edward Wigglesworth Professor of Dermatology Harvard Medical School. He also serves as director of Mass General’s Cutaneous Biology Research Center and director of its multidisciplinary Melanoma Center. A professor of dermatology and pediatrics at Harvard Medical School, Dr. Fisher came to MGH from the Dana-Farber Cancer Institute, where he previously directed the melanoma program. Dr. Fisher’s research has focused on understanding molecular and genetic events which underlie formation of melanoma and skin pigmentation. As a clinician, he has worked to translate these understandings into advances in diagnosis, treatment and prevention of human diseases related to skin and associated disorders. Dr. Fisher is a 2020 inductee into the National Academy of Medicine. In 2022 he was selected to Direct the Melanoma Academy run by the US Department of Defense. And in 2025 he was selected as Fellow of the American Academy of Cancer Research (FAACR).

He received his doctorate under Nobel Laureate Gunter Blobel and Henry Kunkel at Rockefeller University and his medical degree at Cornell Medical College. Dr. Fisher’s specialty training in Medicine, Pediatrics, Oncology were carried out at MGH, Dana-Farber, Boston Children’s, Brigham and Women’s. His research contributions include elucidation of the pathway through which UV radiation induces pigmentation, identification of MITF as master transcriptional regulator in melanocytes and melanoma oncogene, novel approaches to melanoma treatment and prevention, and discovery of the link between ultraviolet radiation and addictive behaviors.

Ryan Stidham is a translational scientist caring exclusively for patients with Crohn’s disease and ulcerative colitis. Ryan joined Mayo Clinic Florida in 2025 with a joint appointment in the Division of Gastroenterology and the Department of Artificial Intelligence and Informatics, where he serves as the Director of AI Clinical Partnerships. Prior to this he was a tenured Professor in both the Department of Computational Medicine & Bioinformatics and Department of Medicine where he served as the Associate Chair of Translational Research.

His research focus is technology development for improving disease activity measurement, clinical trial endpoint development, and automating care in IBD. Dr. Stidham’s research team has been supported by the National Institutes of Health, the Department of Defense, the National Science Foundation, the Crohn’s and Colitis Foundation, the Broad Foundation, the Leona Helmsley Charitable Trust, and several industry sponsored research collaborations. His team's work has been licensed by several technology companies and is being actively used in drug development.

Dr. Stidham received his medical degree from the University of Virginia School of Medicine, completed his internal medicine training at the University of Pennsylvania, and was an NIH T-32 Research Fellow of Gastroenterology at the University of Michigan. Dr. Stidham has advanced training in medical imaging physics, signals analysis, electronic data management, and clinical research design and statistical analysis.

David E. Fisher, MD, PhD, Chief of the Massachusetts General Hospital Department of Dermatology from 2008 to 2025, is the Edward Wigglesworth Professor of Dermatology Harvard Medical School. He also serves as director of Mass General’s Cutaneous Biology Research Center and director of its multidisciplinary Melanoma Center. A professor of dermatology and pediatrics at Harvard Medical School, Dr. Fisher came to MGH from the Dana-Farber Cancer Institute, where he previously directed the melanoma program. Dr. Fisher’s research has focused on understanding molecular and genetic events which underlie formation of melanoma and skin pigmentation. As a clinician, he has worked to translate these understandings into advances in diagnosis, treatment and prevention of human diseases related to skin and associated disorders. Dr. Fisher is a 2020 inductee into the National Academy of Medicine. In 2022 he was selected to Direct the Melanoma Academy run by the US Department of Defense. And in 2025 he was selected as Fellow of the American Academy of Cancer Research (FAACR).

He received his doctorate under Nobel Laureate Gunter Blobel and Henry Kunkel at Rockefeller University and his medical degree at Cornell Medical College. Dr. Fisher’s specialty training in Medicine, Pediatrics, Oncology were carried out at MGH, Dana-Farber, Boston Children’s, Brigham and Women’s. His research contributions include elucidation of the pathway through which UV radiation induces pigmentation, identification of MITF as master transcriptional regulator in melanocytes and melanoma oncogene, novel approaches to melanoma treatment and prevention, and discovery of the link between ultraviolet radiation and addictive behaviors.

Ryan Stidham is a translational scientist caring exclusively for patients with Crohn’s disease and ulcerative colitis. Ryan joined Mayo Clinic Florida in 2025 with a joint appointment in the Division of Gastroenterology and the Department of Artificial Intelligence and Informatics, where he serves as the Director of AI Clinical Partnerships. Prior to this he was a tenured Professor in both the Department of Computational Medicine & Bioinformatics and Department of Medicine where he served as the Associate Chair of Translational Research.

His research focus is technology development for improving disease activity measurement, clinical trial endpoint development, and automating care in IBD. Dr. Stidham’s research team has been supported by the National Institutes of Health, the Department of Defense, the National Science Foundation, the Crohn’s and Colitis Foundation, the Broad Foundation, the Leona Helmsley Charitable Trust, and several industry sponsored research collaborations. His team's work has been licensed by several technology companies and is being actively used in drug development.

Dr. Stidham received his medical degree from the University of Virginia School of Medicine, completed his internal medicine training at the University of Pennsylvania, and was an NIH T-32 Research Fellow of Gastroenterology at the University of Michigan. Dr. Stidham has advanced training in medical imaging physics, signals analysis, electronic data management, and clinical research design and statistical analysis.

Meghan Heberton, MD is an Assistant Professor of Dermatology at UT Southwestern Medical Center. She is boarded in both internal medicine and dermatology. In 2022 she moved to Dallas and UTSW to found and direct the Oncodermatology Program at Simmons Cancer Center. The program provides comprehensive dermatologic care to patients treated at the cancer center. She is an expert in cutaneous toxicities to cancer therapeutics, graft versus host disease, cancer associated dermatoses, and general dermatolgic care of the cancer patient. She also attends the UT Southwestern High Complexity Medical Dermatology Clinic. She is passionate about her field and the mentoring and education of trainees.

Dr. Heather Goff is a Professor of Dermatololgy at UT Southwestern Medical Center in Dallas, Texas where she directs a clinic in the treatment of cutaneous lymphomas. She is a course director for dermatology at UT Southwestern medical school and was a founding member of the Basic Dermatology Curriculum Workgroup at the American Academy of Dermatology. She utilizes her background in fine art to collaborate with local art museums in a medical school elective entitled the Art of Observation.

Dr. Heather Goff is a Professor of Dermatololgy at UT Southwestern Medical Center in Dallas, Texas where she directs a clinic in the treatment of cutaneous lymphomas. She is a course director for dermatology at UT Southwestern medical school and was a founding member of the Basic Dermatology Curriculum Workgroup at the American Academy of Dermatology. She utilizes her background in fine art to collaborate with local art museums in a medical school elective entitled the Art of Observation.

Meghan Heberton, MD is an Assistant Professor of Dermatology at UT Southwestern Medical Center. She is boarded in both internal medicine and dermatology. In 2022 she moved to Dallas and UTSW to found and direct the Oncodermatology Program at Simmons Cancer Center. The program provides comprehensive dermatologic care to patients treated at the cancer center. She is an expert in cutaneous toxicities to cancer therapeutics, graft versus host disease, cancer associated dermatoses, and general dermatolgic care of the cancer patient. She also attends the UT Southwestern High Complexity Medical Dermatology Clinic. She is passionate about her field and the mentoring and education of trainees.

Dr. Swanson is a board-certified dermatologist and pediatric dermatologist. She obtained her medical degree from Tulane University School of Medicine in New Orleans. She performed her dermatology residency at Mayo Clinic in Rochester, Minnesota. After that, she completed a fellowship in Pediatric Dermatology at Phoenix Children’s Hospital in Arizona. She was in private practice in Colorado from 2011 thru 2020. She moved to Boise, Idaho in summer 2020 to become the first and only pediatric dermatologist in the state of Idaho.

She is active in local and national medical societies and organizations. She loves lecturing at conferences discussing pediatric dermatology with audiences across the country. Since moving to Idaho, she works in private practice at Ada West Dermatology and she is on staff at St Luke’s Children’s Hospital where she sees hospital consults and performs procedures.

Dr. Jennifer Cao completed her medical degree at Baylor College of Medicine, followed by an Internal Medicine internship at Carolinas Medical Center, and ophthalmology residency at the University of Colorado. She then completed a fellowship in Uveitis and Ocular Immunology at the Massachusetts Eye and Surgery Institution (MERSI) with Dr. Stephen Foster, who is widely regarded as the “father” of modern uveitis care.
Dr. Cao is a board certified ophthalmologist and is an Associate Professor in the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas, Texas. She is one of the rare uveitis specialists whose practice is 100% comprised of uveitis and ocular inflammatory disease patients, and who also manages the full spectrum of immunomodulatory therapies for her patients.

Dr. Jennifer Cao completed her medical degree at Baylor College of Medicine, followed by an Internal Medicine internship at Carolinas Medical Center, and ophthalmology residency at the University of Colorado. She then completed a fellowship in Uveitis and Ocular Immunology at the Massachusetts Eye and Surgery Institution (MERSI) with Dr. Stephen Foster, who is widely regarded as the “father” of modern uveitis care.
Dr. Cao is a board certified ophthalmologist and is an Associate Professor in the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas, Texas. She is one of the rare uveitis specialists whose practice is 100% comprised of uveitis and ocular inflammatory disease patients, and who also manages the full spectrum of immunomodulatory therapies for her patients.

Dr. Swanson is a board-certified dermatologist and pediatric dermatologist. She obtained her medical degree from Tulane University School of Medicine in New Orleans. She performed her dermatology residency at Mayo Clinic in Rochester, Minnesota. After that, she completed a fellowship in Pediatric Dermatology at Phoenix Children’s Hospital in Arizona. She was in private practice in Colorado from 2011 thru 2020. She moved to Boise, Idaho in summer 2020 to become the first and only pediatric dermatologist in the state of Idaho.

She is active in local and national medical societies and organizations. She loves lecturing at conferences discussing pediatric dermatology with audiences across the country. Since moving to Idaho, she works in private practice at Ada West Dermatology and she is on staff at St Luke’s Children’s Hospital where she sees hospital consults and performs procedures.

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

James G. Krueger is Head of the Laboratory for Investigative Dermatology at The Rockefeller University in New York, NY, USA. He also serves as Physician and Co-director of the Center for Clinical and Translational Science at the Rockefeller University Hospital, and as Chief Executive Officer of the Rockefeller University Hospital.

Dr Krueger earned his Bachelor's degree from Princeton University (Princeton, NJ, USA) and a PhD degree in virology and cell biology from The Rockefeller University. He received his medical degree from Cornell University Medical College (New York City), where he also completed an internship in internal medicine and a residency in dermatology. Dr Krueger is certified by the American Board of Dermatology.

His research group at The Rockefeller University was the first to conduct clinical trials with specific, targeted immune antagonists in psoriasis and this work established that elimination of pathogenic Tcells from skin lesions could reverse the full pathological phenotype of psoriasis. Since then, his group has used immune-based therapeutics to dissect inflammatory pathways in psoriasis, Hidradenitis suppurativa (HS), and Atopic dermatitis (AD) as well as other inflammatory skin conditions, and to conduct parallel pharmacogenomic studies that define mechanisms of targeted therapeutics in human populations. Dr Krueger has been an advocate of bidirectional translational research (bench to bedside and back) in humans to dissect pathogenic pathways that cannot be studied in animal models, particularly for skin diseases.

Here's a condensed version under 250 words:

Emma Guttman-Yassky, MD, PhD, is the Waldman Professor of Dermatology and Immunology and Health System Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, New York. She is Director of the Center of Excellence in Eczema, Director of the Laboratory for Inflammatory Skin Diseases, and Co-Director of the Mount Sinai Clinique Skin Aging Center.

Dr. Guttman earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD from Bar-Ilan University, Israel. After completing dermatology training in Israel, she pursued a postdoctoral fellowship at The Rockefeller University, followed by a second dermatology residency at Weill Cornell Medical College, where she obtained American board certification.

Her research focuses on atopic dermatitis (eczema), hair loss disorders, and skin aging. She has made paradigm-shifting discoveries defining the immunologic basis of atopic dermatitis in both adults and children, leading to the development of targeted therapies. Her work has also advanced the understanding and treatment of alopecia areata, scarring alopecia, chronic hand eczema, keloids, ichthyosis, and other inflammatory skin diseases.

Dr. Guttman co-founded the International Eczema Council and is its past president. She has received numerous national and international awards, delivered keynote and plenary lectures worldwide, and authored more than 475 peer-reviewed publications in leading medical journals.

James G. Krueger is Head of the Laboratory for Investigative Dermatology at The Rockefeller University in New York, NY, USA. He also serves as Physician and Co-director of the Center for Clinical and Translational Science at the Rockefeller University Hospital, and as Chief Executive Officer of the Rockefeller University Hospital.

Dr Krueger earned his Bachelor's degree from Princeton University (Princeton, NJ, USA) and a PhD degree in virology and cell biology from The Rockefeller University. He received his medical degree from Cornell University Medical College (New York City), where he also completed an internship in internal medicine and a residency in dermatology. Dr Krueger is certified by the American Board of Dermatology.

His research group at The Rockefeller University was the first to conduct clinical trials with specific, targeted immune antagonists in psoriasis and this work established that elimination of pathogenic Tcells from skin lesions could reverse the full pathological phenotype of psoriasis. Since then, his group has used immune-based therapeutics to dissect inflammatory pathways in psoriasis, Hidradenitis suppurativa (HS), and Atopic dermatitis (AD) as well as other inflammatory skin conditions, and to conduct parallel pharmacogenomic studies that define mechanisms of targeted therapeutics in human populations. Dr Krueger has been an advocate of bidirectional translational research (bench to bedside and back) in humans to dissect pathogenic pathways that cannot be studied in animal models, particularly for skin diseases.

Mark Kaufmann, MD, is a Clinical Professor in the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City and a former President of the American Academy of Dermatology (AAD). Dr. Kaufmann was in solo private practice for 23 years until he joined The Dermatology Group in November 2017. In September 2020, he joined Advanced Dermatology and Cosmetic Surgery as their Chief Medical Officer.
Dr. Kaufmann has served on the AAD Board of Directors as well as serving as Chair for many AAD committees and councils. In addition, Dr. Kaufmann currently serves on the Board of Directors of the American Society for Dermatologic Surgery, the Florida Academy of Dermatology, and is an advisor to the AAD RUC team (Relative Value Scale Update Committee) - a position he has held for over a decade.
Dr. Kaufmann received his medical degree from New York University School of Medicine, completing residency training in dermatology at the Albert Einstein College of Medicine in the Bronx, New York and is board certified in dermatology. Dr. Kaufmann’s contributions to the American Academy of Dermatology have been recognized by his receiving a Presidential Citation in 2013, 2014, 2015, 2017, 2020, 2022, 2024, and 2025. With many articles published on the topic of health information technology, Dr. Kaufmann is a frequent national lecturer, including the AAD Annual Meeting, other national and regional societies, and grand rounds.

Daniel M. Siegel, MD, Clinical Profesor at SUNY Downstate Health Sciences University & former President of the American Academy of Dermatology (AAD) trained in dermatology at Parkland Memorial Hospital in Dallas followed by a Mohs fellowship at Baylor College of Medicine in Houston. He earned an MS in Management and Policy from the W. Averell Harriman School for Management and Policy, SUNY Stony Brook, and holds an Advanced Certificate in Labor/Management.

A diplomate of the American Board of Dermatology and a fellow of the AAD, the American College of Mohs Surgery (ACMS) and the American Society for Mohs Surgery, he has served on the board of directors for many of these societies, including the ACMS, AAD, ADA, WDS, DebRA, Noah Worcester Dermatological Society and is one of the 20 esteemed active members of the New York Dermatological Society.

He served as board member of the International League of Dermatological Societies and International Society of Dermatology He joined the board of IDEOM in 2020.

Dr. Siegel has published over 250 articles, books and book chapters in major medical journals and textbooks. He is a reviewer, editor, or advisor for many dermatology journals. He also served from 2003 to 2010 as the AAD representative to American Medical Association Specialty Society RVS Update Committee (RUC) and currently serves as the AAD alternate advisor to the RUC.

Dr. Siegel received the 2023 AAD Gold Medal, the AAD’s highest award presented on a very selective basis to acknowledge outstanding and exceptional service in the field.

Mark Kaufmann, MD, is a Clinical Professor in the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City and a former President of the American Academy of Dermatology (AAD). Dr. Kaufmann was in solo private practice for 23 years until he joined The Dermatology Group in November 2017. In September 2020, he joined Advanced Dermatology and Cosmetic Surgery as their Chief Medical Officer.
Dr. Kaufmann has served on the AAD Board of Directors as well as serving as Chair for many AAD committees and councils. In addition, Dr. Kaufmann currently serves on the Board of Directors of the American Society for Dermatologic Surgery, the Florida Academy of Dermatology, and is an advisor to the AAD RUC team (Relative Value Scale Update Committee) - a position he has held for over a decade.
Dr. Kaufmann received his medical degree from New York University School of Medicine, completing residency training in dermatology at the Albert Einstein College of Medicine in the Bronx, New York and is board certified in dermatology. Dr. Kaufmann’s contributions to the American Academy of Dermatology have been recognized by his receiving a Presidential Citation in 2013, 2014, 2015, 2017, 2020, 2022, 2024, and 2025. With many articles published on the topic of health information technology, Dr. Kaufmann is a frequent national lecturer, including the AAD Annual Meeting, other national and regional societies, and grand rounds.

Mark Kaufmann, MD, is a Clinical Professor in the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City and a former President of the American Academy of Dermatology (AAD). Dr. Kaufmann was in solo private practice for 23 years until he joined The Dermatology Group in November 2017. In September 2020, he joined Advanced Dermatology and Cosmetic Surgery as their Chief Medical Officer.
Dr. Kaufmann has served on the AAD Board of Directors as well as serving as Chair for many AAD committees and councils. In addition, Dr. Kaufmann currently serves on the Board of Directors of the American Society for Dermatologic Surgery, the Florida Academy of Dermatology, and is an advisor to the AAD RUC team (Relative Value Scale Update Committee) - a position he has held for over a decade.
Dr. Kaufmann received his medical degree from New York University School of Medicine, completing residency training in dermatology at the Albert Einstein College of Medicine in the Bronx, New York and is board certified in dermatology. Dr. Kaufmann’s contributions to the American Academy of Dermatology have been recognized by his receiving a Presidential Citation in 2013, 2014, 2015, 2017, 2020, 2022, 2024, and 2025. With many articles published on the topic of health information technology, Dr. Kaufmann is a frequent national lecturer, including the AAD Annual Meeting, other national and regional societies, and grand rounds.

Daniel M. Siegel, MD, Clinical Profesor at SUNY Downstate Health Sciences University & former President of the American Academy of Dermatology (AAD) trained in dermatology at Parkland Memorial Hospital in Dallas followed by a Mohs fellowship at Baylor College of Medicine in Houston. He earned an MS in Management and Policy from the W. Averell Harriman School for Management and Policy, SUNY Stony Brook, and holds an Advanced Certificate in Labor/Management.

A diplomate of the American Board of Dermatology and a fellow of the AAD, the American College of Mohs Surgery (ACMS) and the American Society for Mohs Surgery, he has served on the board of directors for many of these societies, including the ACMS, AAD, ADA, WDS, DebRA, Noah Worcester Dermatological Society and is one of the 20 esteemed active members of the New York Dermatological Society.

He served as board member of the International League of Dermatological Societies and International Society of Dermatology He joined the board of IDEOM in 2020.

Dr. Siegel has published over 250 articles, books and book chapters in major medical journals and textbooks. He is a reviewer, editor, or advisor for many dermatology journals. He also served from 2003 to 2010 as the AAD representative to American Medical Association Specialty Society RVS Update Committee (RUC) and currently serves as the AAD alternate advisor to the RUC.

Dr. Siegel received the 2023 AAD Gold Medal, the AAD’s highest award presented on a very selective basis to acknowledge outstanding and exceptional service in the field.